Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $17.54, but opened at $16.37. Pulse Biosciences shares last traded at $16.55, with a volume of 4,945 shares traded.
Analysts Set New Price Targets
Separately, StockNews.com raised Pulse Biosciences to a “sell” rating in a report on Friday, September 20th.
View Our Latest Report on Pulse Biosciences
Pulse Biosciences Trading Down 2.6 %
Hedge Funds Weigh In On Pulse Biosciences
Hedge funds and other institutional investors have recently modified their holdings of the stock. BNP Paribas Financial Markets boosted its position in Pulse Biosciences by 63.6% in the 1st quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock valued at $66,000 after buying an additional 2,952 shares during the last quarter. Quest Partners LLC bought a new stake in Pulse Biosciences in the 2nd quarter valued at $91,000. Price T Rowe Associates Inc. MD bought a new stake in shares of Pulse Biosciences in the first quarter worth $88,000. Cetera Advisors LLC bought a new stake in Pulse Biosciences during the 1st quarter worth about $109,000. Finally, PNC Financial Services Group Inc. bought a new position in shares of Pulse Biosciences in the 4th quarter valued at about $242,000. Institutional investors own 76.95% of the company’s stock.
About Pulse Biosciences
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Featured Articles
- Five stocks we like better than Pulse Biosciences
- What Are Growth Stocks and Investing in Them
- When Is the Best Time to Invest in Mutual Funds?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Is NVIDIA Stock in a Correction or Consolidation?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.